- Home
- Publications
- Publication Search
- Publication Details
Title
Individualising Therapy to Minimize Bacterial Multidrug Resistance
Authors
Keywords
-
Journal
DRUGS
Volume 78, Issue 6, Pages 621-641
Publisher
Springer Nature
Online
2018-03-22
DOI
10.1007/s40265-018-0891-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is a randomized trial of a short course of aminoglycoside added to β-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?
- (2018) D.S.Y. Ong et al. CLINICAL MICROBIOLOGY AND INFECTION
- Re: ‘Is a randomized trial of a short course of aminoglycoside added to β-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?’ Pharmacokinetic/pharmacodynamic considerations
- (2018) A. Heffernan et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model
- (2017) Xuejiu Cai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model
- (2017) Iain J Abbott et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- MIC-based dose adjustment: facts and fables
- (2017) Johan W Mouton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria
- (2017) Vincent H. Tam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
- (2017) Erlangga Yusuf et al. Annals of Intensive Care
- Procalcitonin-guided therapy for the initiation of antibiotics in the ED: a systematic review
- (2016) Yuri van der Does et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
- (2016) Jason A. Roberts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration–Approved Antibiotics, 2010–2015
- (2016) Dalia Deak et al. ANNALS OF INTERNAL MEDICINE
- Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
- (2016) Neang S. Ly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii
- (2016) Brian T. Tsuji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance
- (2016) Soon-Ee Cheah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy
- (2016) Fekade Bruck Sime et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling
- (2016) Rajbharan Yadav et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients
- (2016) Antonio D’Avolio et al. DRUGS
- Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
- (2016) H. Nordqvist et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: Part I gram positive bacteria
- (2016) Kristin E. Linder et al. Expert Opinion on Drug Metabolism & Toxicology
- Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
- (2016) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii
- (2016) Justin R. Lenhard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii
- (2016) Gauri G. Rao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii : pharmacodynamics of new dosing strategies
- (2016) Gauri G. Rao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of carbapenems for the treatment ofPseudomonas aeruginosaventilator-associated pneumonia: associations with clinical outcome and recurrence
- (2016) Jared L. Crandon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing ofPseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance
- (2016) Clare C. Walsh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies
- (2016) Michael J. Satlin et al. JOURNAL OF INFECTION
- Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
- (2016) Evelien de Jong et al. LANCET INFECTIOUS DISEASES
- Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock
- (2016) Nicolas Allou et al. Annals of Intensive Care
- Therapeutic drug monitoring of anti-infective agents in critically ill patients
- (2016) Nynke G. L. Jager et al. Expert Review of Clinical Pharmacology
- Novel Approach To Optimize Synergistic Carbapenem-Aminoglycoside Combinations against Carbapenem-Resistant Acinetobacter baumannii
- (2015) Rajbharan Yadav et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations
- (2015) María Díez-Aguilar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin B in Combination with Antimicrobials LackingIn VitroActivity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections
- (2015) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival
- (2015) Nathaniel J. Rhodes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure
- (2015) Justin R. Lenhard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using anIn VitroInfection Model
- (2015) Brian D. VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
- (2015) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
- (2015) Suzanne L. Parker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial
- (2015) Joshua S. Davis et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill
- (2015) Danny Tsai et al. Current Opinion in Critical Care
- Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance?Pseudomonas aeruginosabloodstream infection in elderly patients as a simulation case study
- (2015) Yoann Cazaubon et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia
- (2015) Samuel L. Aitken et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Killing of Streptococcus pneumoniae by azithromycin, clarithromycin, erythromycin, telithromycin and gemifloxacin using drug minimum inhibitory concentrations and mutant prevention concentrations
- (2015) J.M. Blondeau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Vancomycin-associated nephrotoxicity: A meta-analysis of administration by continuous versus intermittent infusion
- (2015) Timothy Hanrahan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations
- (2015) Claire Roger et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk factors for acquisition of multidrug-resistant bacteria in patients with anastomotic leakage after colorectal cancer surgery
- (2015) Dae-Sang Lee et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia
- (2015) O. Pajot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis
- (2015) Claire Roger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection
- (2015) Robert G. Sawyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development
- (2015) Mohd Abdul-Aziz et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoring
- (2015) Menino Osbert Cotta et al. Infectious Diseases
- Fluoroquinolone- and ceftriaxone-based therapy of community-acquired pneumonia in hospitalized patients: The risk of subsequent isolation of multidrug-resistant organisms
- (2014) Robert C. Goldstein et al. AMERICAN JOURNAL OF INFECTION CONTROL
- A Randomized Trial of Loading Vancomycin in the Emergency Department
- (2014) Jamie M. Rosini et al. ANNALS OF PHARMACOTHERAPY
- Relationship between Ceftolozane-Tazobactam Exposure and Selection for Pseudomonas aeruginosa Resistance in a Hollow-Fiber Infection Model
- (2014) Brian D. VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Meropenem Regimens Suppressing Emergence of Resistance in Acinetobacter baumannii with Human Simulated Exposure in anIn VitroIntravenous-Infusion Hollow-Fiber Infection Model
- (2014) Xin Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model
- (2014) Ken Coleman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin and Piperacillin-Tazobactam Against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
- (2014) Thomas J. Dilworth et al. CLINICAL THERAPEUTICS
- How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?
- (2014) T.W. Felton et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia
- (2014) C. Burdet et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment
- (2014) Mary Sandquist et al. Expert Review of Clinical Immunology
- A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow® Inline Nebulizer System in Mechanically Ventilated Patients
- (2014) A. Bruce Montgomery et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone
- (2014) V. de Lastours et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study
- (2014) Frédéric Frippiat et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model
- (2014) G. L. Drusano et al. JOURNAL OF INFECTIOUS DISEASES
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Mutant Prevention Concentrations of Imipenem and Meropenem againstPseudomonas aeruginosaandAcinetobacter baumannii
- (2014) E. Dahdouh et al. TheScientificWorldJOURNAL
- Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inoculum Effects of Ceftobiprole, Daptomycin, Linezolid, and Vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at Inocula of 105and 107CFU Injected into Opposite Thighs of Neutropenic Mice
- (2013) Dong-Gun Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
- (2013) Natasha E. Holmes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa
- (2013) T. W. Felton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2013) Marco Falcone et al. CLINICAL INFECTIOUS DISEASES
- Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis
- (2013) Carolina F. Oliveira et al. CRITICAL CARE MEDICINE
- Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
- (2013) Dario Cattaneo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis
- (2013) Li-guang Liu et al. JOURNAL OF ANTIBIOTICS
- Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
- (2013) Christina Wacker et al. LANCET INFECTIOUS DISEASES
- Resuscitative strategies in traumatic hemorrhagic shock
- (2013) Adrien Bouglé et al. Annals of Intensive Care
- ComparativeIn VitroandIn VivoEfficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa
- (2012) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Front-Loaded Linezolid Regimens Result in Increased Killing and Suppression of the Accessory Gene Regulator System of Staphylococcus aureus
- (2012) Brian T. Tsuji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ciprofloxacin target AUC : MIC ratio is not reached in hospitalized patients with the recommended dosing regimens
- (2012) Michiel Haeseker et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- β-Lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review
- (2012) Mahipal G Sinnollareddy et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
- (2012) L. Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
- (2012) Zoe E. Athanassa et al. INTENSIVE CARE MEDICINE
- Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems
- (2012) Felipe Fernández-Cuenca et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model
- (2012) S. H. Zinner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations
- (2012) B. T. Tsuji et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
- (2012) Fekade Sime et al. Annals of Intensive Care
- TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
- (2011) Federico Pea et al. ANNALS OF PHARMACOTHERAPY
- Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
- (2011) Phillip J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Ciprofloxacin Concentration on the Frequency and Nature of Resistant Mutants Selected fromPseudomonas aeruginosa mutSandmutTHypermutators
- (2011) Natalia R. Morero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preferential Emergence of Reduced Vancomycin Susceptibility in Health Care-Associated Methicillin-Resistant Staphylococcus aureus Isolates during Continuous-Infusion Vancomycin Therapy in anIn VitroDynamic Model
- (2011) Sheryl Zelenitsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Once-Daily Vancomycin against Methicillin-Resistant Staphylococcus aureus in a Hollow-Fiber Infection Model
- (2011) Anthony M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance Emergence Mechanism and Mechanism of Resistance Suppression by Tobramycin for Cefepime for Pseudomonas aeruginosa
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus
- (2011) Mao Hagihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of Aminoglycoside Therapy
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Procalcitonin Algorithms for Antibiotic Therapy Decisions
- (2011) Philipp Schuetz ARCHIVES OF INTERNAL MEDICINE
- Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
- (2011) D. Ben-David et al. CLINICAL MICROBIOLOGY AND INFECTION
- Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
- (2011) Keith A. Rodvold et al. CLINICAL PHARMACOKINETICS
- Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill Intensive Care Unit patients
- (2011) Haiyan Dong et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The revival of fosfomycin
- (2011) Argyris S. Michalopoulos et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
- (2011) Timothy R Walsh et al. LANCET INFECTIOUS DISEASES
- Treatment with Fluoroquinolones or with -Lactam- -Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum- -Lactamase-Producing Klebsiella Species in Hospitalized Patients
- (2010) K. M. Wener et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa
- (2010) B. Layeux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutant Prevention Concentrations of Four Carbapenems against Gram-Negative Rods
- (2010) K. Credito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
- (2010) Roberto Imberti et al. CHEST
- Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case–control study in a French teaching hospital
- (2010) P. Cassier et al. CLINICAL MICROBIOLOGY AND INFECTION
- Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials
- (2010) Petros Kopterides et al. CRITICAL CARE MEDICINE
- Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock
- (2010) Mathias W. Pletz et al. INTENSIVE CARE MEDICINE
- In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin
- (2010) José M. Entenza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
- (2010) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
- (2010) Miguel Sánchez García JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Extracellular concentrations of fosfomycin in lung tissue of septic patients
- (2010) V. Matzi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Support for higher ciprofloxacin AUC24/MIC targets in treating Enterobacteriaceae bloodstream infection
- (2010) S. A. Zelenitsky et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
- (2010) R. V. Dudhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
- (2010) Lila Bouadma et al. LANCET
- Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
- (2010) Michael A. Kohanski et al. MOLECULAR CELL
- Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients
- (2009) F. Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differing Effects of Combination Chemotherapy with Meropenem and Tobramycin on Cell Kill and Suppression of Resistance of Wild-Type Pseudomonas aeruginosa PAO1 and Its Isogenic MexAB Efflux Pump-Overexpressed Mutant
- (2009) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia*
- (2009) Emmanuel Boselli et al. CRITICAL CARE MEDICINE
- Pharmacokinetic issues for antibiotics in the critically ill patient
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing
- (2009) Vincent H. Tam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia
- (2009) F. Scaglione et al. EUROPEAN RESPIRATORY JOURNAL
- Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution
- (2009) Olivier Baldesi et al. INTENSIVE CARE MEDICINE
- Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria
- (2009) Bruno Fantin et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2008) W. E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Modeling of Aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: Identifying Dosing Regimens To Suppress Resistance Development
- (2008) V. H. Tam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
- (2008) Peggy S. McKinnon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
- (2008) P. J. Bergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study
- (2008) Arthur R.H. van Zanten et al. JOURNAL OF CRITICAL CARE
- Decrease in Bacterial Load Versus Resistance Selection of Pneumococcal Subpopulations by β-Lactam Physiological Concentrations over Time: An In Vitro Pharmacodynamic Simulation
- (2008) Fabio Cafini et al. Microbial Drug Resistance
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
- (2008) Irith Wiegand et al. Nature Protocols
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started